Ampersand Investments

Ampersand has invested in 40 companies and its latest investment was VIVEbiotech on Dec 03, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

-
Dec 03, 2024
-
Flagship Biosciences is a Colorado-based spatial biology company that provides services such as flow cytometry and biomarker development for the pharmaceutical sector.
$5M
Apr 09, 2024
-
Julius Clinical is a Netherlands-based CRO that provides services such as clinical trial management, reporting, and medical monitoring for the healthcare industry.
-
Nov 28, 2023
-
ProtaGene is a Germany-based CRO that provides services such as molecular bioanalysis and vector characterization for biopharmaceutical companies.
-
Nov 20, 2023
-
Genezen is an Indiana-based CDMO that offers services such as viral vector manufacturing and testing for the healthcare sector.
$18.5M
Nov 01, 2023
-

Frequently Asked Questions about Ampersand

  1. What is Ampersand investing in?

    Ampersand has invested in 40 companies including VIVEbiotech, Flagship Biosciences and Julius Clinical
  2. What company did Ampersand invest in?

    Ampersand invested in a total 40 companies including VIVEbiotech, Flagship Biosciences and Julius Clinical
  1. What are the top 5 investments by Ampersand?

    The top companies in which Ampersand invested are VIVEbiotech, Flagship Biosciences, Julius Clinical, ProtaGene and Genezen